Shares of HIMS experienced a dramatic drop today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by nearly fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it co